Lot certificates published
Plain, secure packaging

same family

Semaglutide vs Liraglutide

Semaglutide and liraglutide are distinct acylated GLP-1 analogs. The Library records separate molecular identities for them.

Published: 2026-10-03Library record comparison: 2026-10-03

01

Identity side by side

Recorded molecular identities of Semaglutide and Liraglutide
Recorded fieldSemaglutideLiraglutide
Canonical nameSemaglutideLiraglutide
Aliasesnot recordednot recorded
Development codesNN9535; NNC 0113-0217NN2211
CAS910463-68-2204656-20-2
UNII53AXN4NNHX839I73S42A
PubChem CID5684333116134956
Molecular formulaC187H291N45O59C172H265N43O51
Molecular weight (Da)41143751
Sequence length (residues)3131
Terminal modificationsFree N-terminus; Free C-terminal carboxylFree N-terminus; Free C-terminal carboxyl
Structural modificationsAib substitution at position 8; Arg substitution at position 34; Lys26 derivatization with a fatty-diacid-containing side chainK28R (Lys34Arg in GLP-1 numbering); Lys20 side chain N-epsilon-acylated with N-alpha-palmitoyl-L-glutamyl through the glutamate gamma-carboxyl (Lys26 in GLP-1 numbering)

Semaglutide: nomenclature notes

PubChem lists NN9535 and NNC 0113-0217 as development identifiers for the semaglutide molecular record. WHO Proposed INN List 101 and Recommended List 63 print position 8 in English as 2-amino-2-propanoic acid, without the methyl that their French and Spanish names include; this record keeps Aib, 2-aminoisobutyric acid.

Liraglutide: nomenclature notes

PubChem lists NN2211 as a development identifier for the liraglutide molecular record.

02

Recorded modification details

An aligned one-letter sequence is not recorded for this pair. The stored modification and sequence notes are shown below.

Semaglutide

Terminal modifications
Free N-terminus; Free C-terminal carboxyl
Structural modifications
Aib substitution at position 8; Arg substitution at position 34; Lys26 derivatization with a fatty-diacid-containing side chain
Stored three-letter notation
His · Aib · Glu · Gly · Thr · Phe · Thr · Ser · Asp · Val · Ser · Ser · Tyr · Leu · Glu · Gly · Gln · Ala · Ala · Lys · Glu · Phe · Ile · Ala · Trp · Leu · Val · Arg · Gly · Arg · Gly
Sequence notes
Thirty-one residues in the conventional GLP-1 7-37 numbering this library keeps for every analog built on that scaffold: the first token is His7 and the last is Gly37, so a position number in this entry is the array index plus six, and Lys26 is the twentieth token. NO one-letter string is published here. Position 8 is Aib, 2-aminoisobutyric acid; written as Ala it would name the native residue this analog exists to replace, and any other letter would name a different amino acid again. The IUPHAR/BPS Guide to Pharmacology (ligand 9724, release 2026.3.1) prints Ala at position 8 in its sequence fields while its structure encodes Aib; FDA GSRS also records Aib there. The backbone is also not the whole molecule: the Lys26 side chain is acylated through two AEEA spacers and a gamma-L-glutamyl unit to a C18 dicarboxylic fatty acid. Summing the thirty-one residues with Aib at position 8 and Arg at position 34, removing thirty waters, then adding two AEEA units, one glutamyl unit and octadecanedioic acid less the four waters of the four amide bonds, gives C187H291N45O59 and an average mass of 4113.64 Da, reproducing the recorded formula exactly and the recorded mass to 0.36 Da. Against the machine-verified GLP-1(7-37) entry that backbone differs by exactly CH2 and N2 — the Aib8 and Arg34 substitutions, and nothing else. That arithmetic is the identity check this record rests on; the automated sequence verifier cannot reach it, because Aib and the acyl side chain are both outside its derivation model.

Liraglutide

Terminal modifications
Free N-terminus; Free C-terminal carboxyl
Structural modifications
K28R (Lys34Arg in GLP-1 numbering); Lys20 side chain N-epsilon-acylated with N-alpha-palmitoyl-L-glutamyl through the glutamate gamma-carboxyl (Lys26 in GLP-1 numbering)
Stored three-letter notation
His · Ala · Glu · Gly · Thr · Phe · Thr · Ser · Asp · Val · Ser · Ser · Tyr · Leu · Glu · Gly · Gln · Ala · Ala · Lys · Glu · Phe · Ile · Ala · Trp · Leu · Val · Arg · Gly · Arg · Gly
Sequence notes
Thirty-one main-chain residues numbered 1-31, which are GLP-1 residues 7-37: a GLP-1 position number is the array index plus six. Arg28 is the Lys34Arg substitution. The Lys20 side chain (Lys26 in GLP-1 numbering) carries an N-alpha-palmitoyl-L-glutamyl group joined through the glutamate gamma-carboxyl; that glutamate belongs to the side chain, not the main chain, and the one-letter string cannot show it. PubChem CID 16134956 encodes this structure with a free N-terminus and a free C-terminal carboxyl. Summing the thirty-one residues and removing thirty waters, then adding the glutamyl unit and the palmitoyl group less the two waters of their amide bonds, gives C172H265N43O51 and 3751.26 Da, reproducing the recorded formula.

03

Recorded mechanisms

These lists show the links recorded in each monograph. An unlisted link does not establish its absence from the molecule’s biology.

Recorded only for Semaglutide

not recorded

Recorded only for Liraglutide

not recorded

04

Recorded compound classes

Shared recorded links

Recorded only for Semaglutide

not recorded

Recorded only for Liraglutide

not recorded

05

References for the relationship

  1. Reference 1

    Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.

    Lau J, Bloch P, Schäffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, Strauss HM, Gram DX, Knudsen SM, Nielsen FS, Thygesen P, Reedtz-Runge S, Kruse T

    Journal of medicinal chemistry · 2015-09-11 · Journal Article

    current
  2. Reference 2

    The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

    Secher A, Jelsing J, Baquero AF, Hecksher-Sørensen J, Cowley MA, Dalbøge LS, Hansen G, Grove KL, Pyke C, Raun K, Schäffer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, Bjerre Knudsen L

    The Journal of clinical investigation · 2014-09-09 · Journal Article

    current

Study models of these references

What kind of experiment each cited paper reports, taken from its abstract unless marked. Not a summary of results.

ReferenceStudy models
Lau J et al. 2015Study models reported: in vitro; animal (mini-pig) · from the abstract
Secher A et al. 2014Study models reported: in vitro; animal (rat, mouse) · from the abstract

06

Read the full monographs